Jessie Nicodemus‐Johnson
Jessie Nicodemus‐Johnson publishes mostly in Molecular Biology, Physiology and Public Health, Environmental and Occupational Health, on topics such as Epigenetics and DNA Methylation, Alzheimer's disease research and treatments and Statistical Methods in Clinical Trials.
- World rank
- #1,923,589 of 7,710,434 ranked researchers
- Rank in United States
- #586,720 of 1,627,098
- Works
- 42
- Citations
- 946
- Citations per work
- 22.5
What does Jessie Nicodemus‐Johnson research?
Jessie Nicodemus‐Johnson's work is mostly in Biochemistry, Genetics and Molecular Biology (21%), Medicine (20%), Mathematics (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1739.6%
- Life Sciences1227.7%
- Health Sciences819.8%
- Medicine819.8%
- Physical Sciences37.9%
- Mathematics37.9%
- Social Sciences25.0%
- 1Molecular Biology21% of their works
- 2Physiology11% of their works
- 3Public Health, Environmental and Occupational Health9% of their works
- 4Statistics and Probability8% of their works
- 5Immunology7% of their works
- 6Economics and Econometrics5% of their works
Research topics
- Epigenetics and DNA Methylation
- Alzheimer's disease research and treatments
- Statistical Methods in Clinical Trials
- Asthma and respiratory diseases
- Dementia and Cognitive Impairment Research
- Health Systems, Economic Evaluations, Quality of Life
- Reproductive System and Pregnancy
- Computational Drug Discovery Methods
Which keywords describe Jessie Nicodemus‐Johnson's research?
The keywords of their largest research topics: Biomarkers, DNA Methylation, Histone Modification, Amyloid Hypothesis, Tau Pathology, Adaptive Designs, Allergic Diseases and Alzheimer's Disease.
- Regulatory T Cells
- Decidual NK Cells
- Mild Cognitive Impairment
- Cost-effectiveness Analysis
- Alzheimer's Disease
- Adaptive Designs
- Amyloid Hypothesis
- DNA Methylation
- Biomarkers
- Histone Modification
- Tau Pathology
- Allergic Diseases
- Asthma
- False Discovery Rate
- Quality of Life
- Molecular Docking
- Virtual Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Biomarkers82 topics
- DNA Methylation61 topic
- Histone Modification61 topic
- Amyloid Hypothesis51 topic
- Tau Pathology51 topic
- Adaptive Designs41 topic
- Allergic Diseases41 topic
- Alzheimer's Disease41 topic
- Asthma41 topic
- Cost-effectiveness Analysis41 topic
- False Discovery Rate41 topic
- Mild Cognitive Impairment41 topic
- Quality of Life41 topic
- Decidual NK Cells31 topic
- Molecular Docking31 topic
- Regulatory T Cells31 topic
- Virtual Screening31 topic
Where does Jessie Nicodemus‐Johnson work?
Jessie Nicodemus‐Johnson's main affiliation in the publication record is TetraLogic Pharmaceuticals (United States), United States.
How many publications and citations does Jessie Nicodemus‐Johnson have?
OpenAlex counts 42 works and 946 citations for Jessie Nicodemus‐Johnson, an h-index of 15, ranking #1,923,589 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jessie Nicodemus‐Johnson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.